688314.SS
Get informed when a big investor buys or sells
+ FollowUndervalued by 32.6% based on the discounted cash flow analysis.
| Market cap | $2.40 Billion |
|---|---|
| Enterprise Value | $2.19 Billion |
| Dividend Yield | $0.52 (1.60%) |
| Earnings per Share | $1.22 |
| Beta | 0.01 |
| Outstanding Shares | 81,628,272 |
| P/E Ratio | 27.95 |
|---|---|
| PEG | -318.57 |
| Price to Sales | 7.28 |
| Price to Book Ratio | 3.23 |
| Enterprise Value to Revenue | 6.24 |
| Enterprise Value to EBIT | 23.69 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.12 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Kontour (Xi'an) Medical Technology Co., Ltd. engages in the research and development, production, and sale of Class III implantable medical devices in China. The company offers products in the fields of neurosurgery cranial repair and fi...